Lisinopril Cost in Georgia 2026: Cash Prices, Medicaid, Insurance, and Discount Options

What Does Lisinopril Actually Cost in Georgia in 2026?

Generic lisinopril is one of the most affordable prescription drugs available in Georgia, with a statewide average cash-pay price of approximately $8 per month for a 30-tablet supply of the 10 mg dose. The manufacturer list price sits near $50 per month, but that figure rarely reflects what patients pay at the counter. Most Georgia residents can access generic lisinopril for well under $15 per month regardless of insurance status.

Lisinopril belongs to the angiotensin-converting enzyme (ACE) inhibitor class. Its core mechanism, blocking the conversion of angiotensin I to angiotensin II, is established in decades of outcomes data [1]. The drug has FDA-approved indications for hypertension, heart failure (as adjunct therapy), and acute myocardial infarction within 24 hours of onset, as well as nephropathy in patients with type 2 diabetes [2].

Price variation across Georgia pharmacies is real. A 30-day supply of generic lisinopril 10 mg can range from roughly $4 at Walmart's $4 generic program to about $15 at independent pharmacies without discount cards. The 40 mg tablet, used in heart failure or resistant hypertension, typically costs $10 to $18 per month cash-pay. Splitting higher-dose tablets is sometimes cost-effective but requires explicit prescriber approval and is not appropriate for all formulations [3].

The ALLHAT trial (N=33,357) demonstrated that lisinopril-based therapy was comparable to chlorthalidone for composite cardiovascular outcomes, establishing it as a first-line antihypertensive across a broad population [4]. That trial's findings underpin guideline recommendations that have kept lisinopril on virtually every formulary since 2002.

Georgia Medicaid Coverage for Lisinopril

Georgia Medicaid (Georgia Pathways and standard Medicaid) covers lisinopril for enrollees with qualifying diagnoses, including hypertension, systolic heart failure, and diabetic nephropathy. Coverage is subject to the standard Georgia Medicaid preferred drug list (PDL), and generic lisinopril is generally listed as preferred, meaning no prior authorization is required for most covered indications.

Georgia's Medicaid program is administered through the Department of Community Health. Enrollees who meet income eligibility criteria and carry a diagnosis supported by ICD-10 coding (such as I10 for essential hypertension or I50.x for heart failure) should expect generic lisinopril to be dispensed at no cost or with a nominal $1 to $3 copay, depending on their specific Medicaid plan category [5].

The AHA and ACC 2017 Hypertension Guidelines recommend ACE inhibitors as first-line therapy for hypertension complicated by heart failure with reduced ejection fraction, chronic kidney disease, or diabetes, making lisinopril a clinically and formulary-supported choice for many Medicaid patients [6]. The guideline states: "ACE inhibitors or ARBs are recommended in patients with hypertension and CKD to slow kidney disease progression" [6].

Patients enrolled in Georgia's Pathways to Coverage program, the state's partial Medicaid expansion under work requirements, have access to a formulary that mirrors the standard Georgia Medicaid PDL. Generic lisinopril is listed in that formulary under the cardiovascular drug class.

For Medicaid enrollees requiring doses above 40 mg daily or combination products, step therapy or prior authorization may apply. Physicians should reference the current Georgia Medicaid PDL published by the Department of Community Health, as updates occur quarterly [5].

Commercial Insurance Coverage in Georgia

Lisinopril is almost universally a Tier 1 drug on commercial insurance formularies in Georgia. Tier 1 represents the lowest copay tier, typically $0 to $10 per fill under most plans offered through the ACA marketplace or employer groups in Georgia.

Major insurers operating in Georgia, including Anthem Blue Cross Blue Shield, Humana, United Healthcare, and Aetna, all list generic lisinopril on Tier 1 of their standard formularies. Patients on high-deductible health plans (HDHPs) may pay full cash price until their deductible is met, though that cash price remains around $8 per month at discount pharmacies, making the financial exposure minimal.

Medicare Part D enrollees in Georgia should note that lisinopril appears on the formulary of virtually every stand-alone Part D plan (PDP) and Medicare Advantage plan with drug coverage (MAPD) operating in the state. The 2024 Medicare Drug Price Negotiation Program did not target lisinopril specifically, as the drug is already generic and priced competitively [7]. Average Part D cost-sharing for generic lisinopril is typically $0 to $5 per month in the initial coverage phase.

Patients should confirm their specific plan's formulary on Medicare.gov or via the Summary of Benefits and Coverage document, as cost-sharing can differ by plan. The standard Medicare Part D catastrophic threshold adjustments in 2025 and 2026 reduce beneficiary liability further for low-cost generics [7].

Is Compounded Lisinopril Legal in Georgia?

Compounded lisinopril is legal in Georgia when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription from a licensed prescriber. Georgia follows federal USP Chapter 795 standards for non-sterile compounding and state Board of Pharmacy regulations [8].

A 503A pharmacy compounds medications for individual patients; it does not produce drugs for office stock or resale without a prescription. Lisinopril powder is a commercially available active pharmaceutical ingredient (API) that 503A pharmacies may compound into custom concentrations, oral liquids, or low-dose tablets not available commercially. This is particularly useful for pediatric dosing (lisinopril is used off-label in hypertensive children) or for patients who need doses like 2.5 mg or 7.5 mg [9].

The cost of compounded lisinopril in Georgia varies widely by pharmacy and formulation, but some 503A pharmacies offer compounded oral solutions starting near $0/month when covered by specific insurance arrangements or patient assistance programs. Cash-pay compounded lisinopril oral liquid typically runs $20 to $40 per month, which may be higher than the retail generic tablet.

503B outsourcing facilities, which produce large batches of sterile compounds, are not relevant to oral lisinopril. The FDA's guidance on compounding distinguishes clearly between 503A and 503B facilities [10]. Georgia prescribers writing for compounded lisinopril must document a clinical rationale, and pharmacies must comply with current USP 795 standards effective November 2023 [8].

Telehealth Prescribing of Lisinopril in Georgia

Lisinopril is a Schedule-exempt (non-controlled) prescription drug. Georgia law permits telehealth prescribing of non-controlled medications without a prior in-person visit, provided the prescriber establishes a valid patient-provider relationship through an appropriate telehealth encounter [11].

The Georgia Composite Medical Board and the 2020 Georgia Telehealth Act (O.C.G.A. § 33-24-56.4) both support the validity of telehealth-initiated prescriptions for drugs like lisinopril. Prescribers must conduct a clinically appropriate evaluation, including a review of blood pressure history, kidney function (eGFR), serum potassium, and relevant comorbidities, before initiating an ACE inhibitor [11].

Monitoring requirements are not relaxed by the telehealth format. The 2017 AHA/ACC Guideline recommends checking serum creatinine and potassium within two to four weeks of initiating an ACE inhibitor or dose change, as both can rise, particularly in patients with underlying CKD or those taking potassium-sparing diuretics [6]. A rise in serum creatinine of up to 30% from baseline is generally acceptable and does not warrant discontinuation, per the guideline [6].

Telehealth platforms prescribing lisinopril in Georgia typically require patients to complete home blood pressure logs or submit validated readings from connected devices. This supports the ongoing monitoring needed to titrate doses appropriately, as the usual maintenance range is 10 to 40 mg once daily for hypertension [2].

Discount Programs and Savings Cards for Lisinopril in Georgia

Multiple discount mechanisms can reduce the already-low cost of lisinopril in Georgia to near zero. GoodRx, RxSaver, NeedyMeds, and pharmacy-specific $4 generic programs are the primary options available without insurance enrollment.

GoodRx prices for generic lisinopril 10 mg (30 tablets) at major Georgia chains cluster between $4 and $9. Kroger Pharmacy, CVS, Walgreens, and Publix all participate in GoodRx's network. Publix specifically offers a free 30-day supply of generic lisinopril through its free antibiotic and generic medication program, which has been available at Georgia Publix locations for several years [12]. This program requires a valid prescription and proof of the applicable Publix offer but does not require insurance.

Walmart's $4 generic prescription program includes lisinopril in standard doses. A 90-day supply costs $10 at Walmart, equating to about $3.33 per month, the lowest documented retail cash price in Georgia for this drug [13].

NeedyMeds maintains a database of patient assistance programs (PAPs) for patients who cannot afford their medications. While brand-name lisinopril (Zestril) was discontinued, some PAPs offered by cardiac-focused nonprofits cover generic ACE inhibitors for income-qualifying patients [14].

State-level programs in Georgia, including the Georgia Drug Card and various county health department programs, may also provide additional discounts. The Georgia Department of Public Health's chronic disease management resources reference community health centers (FQHCs) that can dispense medications at reduced cost through the federal 340B drug pricing program [15].

How to Choose the Cheapest Lisinopril Option in Georgia

The cheapest path depends on your insurance status and the dose prescribed. Here is a concrete framework based on 2026 Georgia pricing:

No insurance: Use the Publix free generic program for standard doses (5 mg, 10 mg, 20 mg, 40 mg). For doses not covered by Publix, use GoodRx at Kroger or Walmart's $4 program. Expected cost: $0 to $4 per month.

Commercial insurance, Tier 1: Pay the copay, which is typically $0 to $10. If the copay exceeds the GoodRx cash price, ask the pharmacist to bill the GoodRx price instead. Pharmacists can apply a discount card instead of insurance when it is cheaper [16].

Medicare Part D: Most plans cover generic lisinopril at $0 in 2026 due to the insulin-adjacent low-cost generic benefit expansions under the Inflation Reduction Act; verify your specific plan's cost-sharing document [7].

Georgia Medicaid: Expect $0 to $3 per fill for a covered indication. No additional discount card is needed or applicable on top of Medicaid billing [5].

Compounded lisinopril: Only cost-effective when a specific concentration not commercially available is clinically required. Standard tablet generics are nearly always cheaper.

Blood pressure control rates in treated hypertensive patients remain suboptimal nationally. The CDC reports that among U.S. adults with hypertension, only 43.7% have their blood pressure under control [17]. Cost barriers, while reduced for lisinopril, remain a documented contributor to non-adherence, and selecting the lowest-cost access pathway directly supports treatment persistence.

Clinical Context: Why Lisinopril Remains a First-Line Choice in Georgia and Nationally

Lisinopril's continued placement on first-line formularies is not purely historical. The evidence base is extensive and the safety profile is well characterized over four decades of use.

The ALLHAT trial randomized 33,357 high-risk hypertensive patients aged 55 and older to chlorthalidone, amlodipine, or lisinopril. At mean follow-up of 4.9 years, the primary composite outcome (fatal coronary heart disease or nonfatal MI) did not differ significantly between the three arms, with event rates of 11.5% (chlorthalidone), 11.3% (amlodipine), and 11.4% (lisinopril) [4]. This equivalence in hard cardiovascular outcomes across drug classes confirmed lisinopril as an appropriate first-line agent for a broad hypertensive population.

For patients with heart failure with reduced ejection fraction (HFrEF), the CONSENSUS trial (N=253) showed that enalapril (a closely related ACE inhibitor) reduced 6-month mortality by 40% compared to placebo [18]. Lisinopril's role in HFrEF is supported by similar mechanism and by the ATLAS trial, which compared low-dose (2.5 to 5 mg/day) versus high-dose (32.5 to 35 mg/day) lisinopril in 3,164 HFrEF patients over a median of 45.7 months. High-dose lisinopril reduced the risk of death or hospitalization by 12% (P<0.001) [19].

Renal protection in diabetic nephropathy is another documented benefit. The Collaborative Study Group trial (N=409) showed that captopril (ACE inhibitor class) reduced the risk of doubling of serum creatinine by 48% compared to placebo over 3 years in patients with type 1 diabetes and proteinuria [20]. Guideline extrapolation to lisinopril for type 2 diabetic nephropathy is supported by the FDA label and by the ADA Standards of Medical Care, which recommend ACE inhibitors or ARBs for patients with diabetes and albuminuria [21].

Dry cough affects roughly 10% to 15% of patients taking lisinopril, representing the most common reason for discontinuation [22]. Angioedema occurs in approximately 0.1% to 0.7% of patients, with higher rates in Black patients, a factor that affects prescribing decisions in Georgia given the state's substantial Black population and the higher burden of hypertension in this group [23]. When cough or angioedema occurs, angiotensin receptor blockers (ARBs) such as losartan are an appropriate alternative and are similarly priced in Georgia's generic market.

Hyperkalemia is a clinically significant risk, particularly in patients with eGFR <45 mL/min/1.73m2 or those taking potassium supplements, potassium-sparing diuretics, or trimethoprim. Baseline metabolic panel and follow-up labs at two to four weeks after initiation are standard of care [6].

Monitoring and Dose Titration for Georgia Patients

Starting doses for hypertension are typically 10 mg once daily. Patients who are volume-depleted, elderly, or have baseline eGFR <30 should start at 2.5 to 5 mg daily to reduce first-dose hypotension risk [2]. The maximum approved dose for hypertension is 40 mg daily, though doses above 20 mg/day show diminishing antihypertensive returns in most patients.

For heart failure, titration is slower. Starting at 2.5 to 5 mg daily and doubling every two weeks as tolerated to target doses of 20 to 40 mg daily mirrors the ATLAS trial protocol and current heart failure guideline recommendations from the ACC/AHA [24].

Labs to monitor after initiation or dose change include serum creatinine, blood urea nitrogen, and serum potassium. A creatinine rise of more than 30% from baseline or potassium above 5.5 mEq/L warrants dose reduction or discontinuation and specialist consultation [6].

Blood pressure targets per the 2017 AHA/ACC Guideline are below 130/80 mmHg for most adults with confirmed hypertension, defined as average systolic blood pressure at or above 130 mmHg or diastolic at or above 80 mmHg [6]. Georgia's own chronic disease burden data from the Georgia Department of Public Health support aggressive target attainment given the state's above-average prevalence of hypertension-related stroke and kidney disease [25].